Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 11, 2003, Pages 1903-1905

  Takeuchi, Kumiko ^a   Kohn, Todd J ^a   Honigschmidt, Nicholas A ^a   Rocco, Vincent P ^a   Spinazze, Patrick G ^a   Koch, Daniel J ^a   Nelson, David L ^a   Wainscott, D Bradley ^a   Ahmad, Laura J ^a   Shaw, Janice ^a   Threlkeld, Penny G ^a   Wong, David T ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1H INDOL 4 YLOXY) 3 (4 BENZO[B]THIOPHEN 2 YLPIPERIDINYL)PROPAN 2 OL; PIPERIDINE DERIVATIVE; SEROTONIN 1A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG IDENTIFICATION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; PHARMACOPHORE; STRUCTURE ACTIVITY RELATION;

EID: 12444336976     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00303-2     Document Type: Article

References (12)

1. Asberg M., Eriksson B., Martensson B., Traskman-Bendz L., Wagner A. J. Clin. Psychiatr. 47(Suppl.):1986;23.
2. Schatzberg A.F., Dessain E., O'Neil P., Katz D.L., Cole J.O. J. Clin Psychopharmacol. 7:1987;44. S-49S.
3. Rutter J.J., Gundlah C., Auerbach S.B. Synapse. 20:1995;225.
4. Hjorth S. J. Neurochem. 60:1993;776.
5. Artigas F., Perez V., Alvarez E. Arch. Gen. Psychiatry. 51:1994;248.
6. Gartside S.E., Umbers V., Hajos M., Sharp T. Br. J. Pharmacol. 115:1995;1064.
7. Dreshfield L.J., Wong D.T., Perry K.W., Engleman E.A. Neurochem. Res. 21:1996;557.
8. Meagher K.L., Mewshaw R.E., Evrard D.A., Zhou P., Smith D.L., Scerni R., Spangler T., Abulhawa S., Shi X., Schechter L.E., Andree T.H. Bioorg. Med. Chem. Lett. 11:2001;1885.
9. Martinez J., Pérez S., Oficialdegui A.M., Heras B., Orús L., Villanueva H., Palop J.A., Roca J., Mourelle M., Bosch A., Del Castillo J.-C., Lasheras B., Tordera R., del Rio J., Monge A. Eur. J. Med. Chem. 36:2001;55.
10. 1A receptor with standard assay techniques as previously described: Weinshank R.L., Zgombick J.M., Macchi M.J., Brancheck T.A., Hartig P.R. Proc. Natl. Acad. Sci. U.S.A. 89:1992;3630.
11. Radioligand assays were performed in triplicates, using rat frontal cortex membranes: Wong D.T., Threlkeld P.G., Robertson D.W. Neuropsychopharmacology. 5:1991;43.
12. The method was based on an assay previously described but adapted to a scintillation proximity assay (SPA) format. See Rasmussen K., Calligaro D.O., Czachura J.F., Dreshfield-Ahmad L.J., Evans D.C., Hemrick-Luecke S.K., Kallman M.J., Kendrick W.T., Leander J.D., Nelson D.L., Overshiner C.D., Wainscott D.B., Wolff M.C., Wong D.T., Brancheck T.A., Zgombick J.M., Xu Y.-C. J. Pharmacol. Exp. Ther. 294:2000;688.